TARGETING THE ZER1 UBIQUITIN LIGASE FOR THE TREATMENT OF HPV+ PENILE, ANAL, AND VULVAR CANCERS

$499,600FY2025Defense Health AgencyDOD

The Broad Institute, Inc

Investigators

TARGETING THE ZER1 UBIQUITIN LIGASE FOR THE TREATMENT OF HPV+ PENILE, ANAL, AND VULVAR CANCERS · GrantIndex